VI
Vizgen, Inc.
SEC filingBiotechnology · Waltham, MA
Amount raised$47.8Msold at filing
Total offering$50M$2.2M still open
Investors in the raise9count reported to the SEC
FiledJan 12, 2026first sale Dec 29, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Andrea JacksonDirector
Simona LeviExecutive Officer
Robert CarsonExecutive Officer, Director
Keith CrandellDirector
Matthew PosardDirector
Christian UhrichDirector
David WaltDirector
Executive officers, directors and promoters as listed on the Form D.